Algert Global’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.23M | Sell |
116,347
-13,973
| -11% | -$508K | 0.09% | 385 |
|
|
2025
Q1 | $4.72M | Buy |
130,320
+47,527
| +57% | +$1.72M | 0.12% | 295 |
|
|
2024
Q4 | $3.48M | Buy |
82,793
+8,891
| +12% | +$374K | 0.08% | 411 |
|
|
2024
Q3 | $4.11M | Buy |
73,902
+23,580
| +47% | +$1.31M | 0.11% | 321 |
|
|
2024
Q2 | $2.07M | Buy |
50,322
+25,752
| +105% | +$1.06M | 0.07% | 457 |
|
|
2024
Q1 | $1.15M | Hold |
24,570
| – | – | 0.04% | 580 |
|
|
2023
Q4 | $1.18M | Buy |
24,570
+2,430
| +11% | +$116K | 0.05% | 577 |
|
|
2023
Q3 | $789K | Sell |
22,140
-4,710
| -18% | -$168K | 0.04% | 618 |
|
|
2023
Q2 | $1.24M | Sell |
26,850
-11,910
| -31% | -$550K | 0.05% | 578 |
|
|
2023
Q1 | $1.55M | Buy |
+38,760
| New | +$1.55M | 0.07% | 431 |
|
|
2022
Q2 | – | Sell |
-3,061
| Closed | -$222K | – | 1348 |
|
|
2022
Q1 | $222K | Sell |
3,061
-1,392
| -31% | -$101K | 0.01% | 1023 |
|
|
2021
Q4 | $374K | Sell |
4,453
-1,800
| -29% | -$151K | 0.05% | 650 |
|
|
2021
Q3 | $564K | Buy |
+6,253
| New | +$564K | 0.08% | 494 |
|